Anti-Inflammation Heralds the Future of CV Medicine

From CANTOS to COLCOT to COPS to LoDoCo2: Dr. Ridker presents the lessons from these trials with anti-inflammatory treatment, in particular those with colchicine, in patients with residual inflammatory risk.

View here